| |
| HEALTHCARE |
Leading Institutions showcase London Clinic
January 28, 2020
Mayo Clinic Healthcare in partnership with Oxford University Clinic, which has opened a new premium preventative healthcare facility in central London, is set to attend Arab Health 2020. The Clinic is joining the HSMA delegation at Arab Health 2020 for the first time – as part of the 18 world-leading clinics and hospital groups showcasing London’s medical"...
SEHA and Vocera Collaborate to Provide World-Class Clinical Communication Across Integrated Healthcare Network
January 28, 2020
Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, is partnering with Abu Dhabi Health Services Company – SEHA, the largest integrated healthcare network in the United Arab Emirates, to implement the Vocera Platform at the new Sheikh Shakhbout Medical City (SSMC). The 732-bed SSMC will be the first hospital within SEHA to standardize care team communication with Vocera solutions. There are future plans for SEHA to deploy the Vocera solution across 11 additional hospitals in the region. Caregivers will use the wearable Vocera Smartbadge and the Vocera smartphone app to communicate hands-free via voice, send and receive secure messages, manage alerts and alarms, and more. The dynamic master directory of the Vocera Platform will enable clinicians to reach colleagues across the network simply by saying a name, role or group. There......
Emirates Hospital Group participates in Arab Health 2020
January 27, 2020
Emirates Hospital Group, an Emirates Healthcare company, participates in the Arab Health 2020, scheduled to take place from January 27-30 at the Dubai World Trade Center where it offers a patient-centric continuum of care by owning and operating an extensive portfolio of full-service hospitals, specialty clinics, urgent care centers, med-spas and pharmacies. Each entity focuses on the patients’ well-being. Dr Michael Fakih, CEO, Emirates Hospital"...
Omnicell Showcases Latest Advancements to Medication Management Portfolio at Arab Health Exhibition and Congress
January 27, 2020
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced the Company will be showcasing the latest advancements to its medication management portfolio at the Arab Health Exhibition and Congress from 27-30 January in Dubai. Arab Health is the largest gathering of healthcare and trade professionals in the Middle East region. According to a report"...
Takeda Named Global Top 100 Most Sustainable Corporation for Fifth Year Running
January 22, 2020
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) is proud to be named in the Corporate Knights Global 100 Most Sustainable Corporations in the World (Global 100) for the fifth consecutive year. Corporate Knights assesses more than 7,300 companies against 21 key performance indicators. It uses these indicators to determine the top 1% most sustainable companies in the world, which are announced annually at the World Economic Forum in Davos, Switzerland. “Building sustainable value is a fundamental part of the way we do business at Takeda, and we are proud to be recognized as a global leader in sustainability,” said Christophe Weber, President and CEO. “This recognition by Corporate Knights is a testament to the strong foundation Takeda has laid and the progress we have already achieved. We remain steadfast in our commitment to realizing Better......
ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask
January 20, 2020
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market. Full face CPAP users can now choose between a tube-up or tube-down connection, compact under-the-nose or traditional over-the-nose cushion styles, and even memory foam versus silicone cushion. AirFit F30i’s"...
Obesity key to type 2 diabetes, which has quadrupled in the last 35 years
January 20, 2020
Abdulatif, a 73-year old man suffered from complex diabetes which led to kidney failure. Abdulatif, an Emirati by origin weighed 115 kgs and clearly suffered from obesity, a key factor that led to his condition. Research indicates that more than two billion people are overweight or obese globally. Obesity is a major factor for the lead up to type 2 diabetes, which has quadrupled in the last 35 years, and more than 460 million adults in the world now have diabetes. In the UAE, over 64 percent of the population suffers from"...
Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness
January 18, 2020
The Tej Kohli Foundation has moved one step closer to a non-surgical treatment for corneal blindness as it prepares to enter into a collaboration with researchers in Montreal, Canada and Moorfields Eye Hospital, UK to develop the Foundation’s recently acquired proprietary technology into an injectable biosynthetic ‘glue-filler’. The biosynthetic solution is a liquid form that sets as a gel at body temperature and which can then"...
Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan
January 17, 2020
Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong. The partnership covers Samsung Bioepis’ biosimilar candidates in the field of immunology and oncology, including SB5 (adalimumab), SB4 (etanercept), SB3 (trastuzumab), and SB8 (bevacizumab). Through the partnership,"...
Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference
January 15, 2020
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) will provide an update on the progress of its business transformation and priorities today at the 38th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, will share details on Takeda’s portfolio and pipeline strategy, financial outlook, and ongoing sustainability efforts, including its newly established commitment to carbon neutrality across its value chain. “Last year was an important and successful year for Takeda as we accelerated our transformation to become a leading global biopharmaceutical company,” said Mr. Weber. “Our commitment to bringing better health and a brighter future to patients worldwide continues as we expand our global brands and advance our next-generation pipeline, driving sustainable growth. We also recognize that......
|
|
|
|
|